(Vienna, 04 September 2025) On 1 September 2025, the first replacement of the aorta and aortic valve using the newly developed Konect system was successfully performed in Austria at the University Hospital Vienna (Universitätsklinikum AKH Wien). This marks another milestone in the treatment of complex aortic diseases for the Department of Cardiac and Thoracic Aortic Surgery at University Hospital Vienna/MedUni Vienna.
"The Konect system offers us decisive advantages in surgical care – particularly in terms of handling, precision and patient safety," explains Marek Ehrlich, Director of the Aortic Programme at University Hospital Vienna. Particularly noteworthy is the integration of RESILIA Tissue, an innovative biological tissue that is protected against calcification by a special treatment technology. This significantly extends the durability of the implant, thereby improving the long-term prognosis for patients. In addition, the Konect system features optimised suture guidance and precise anatomical adaptation, which can shorten operating time and reduce the risk of intraoperative complications. "For us surgeons, this combination of innovative tissue material and advanced implant technology not only makes our work in the operating theatre easier, but above all offers a lasting benefit for our patients," says Ehrlich.
Daniel Zimpfer, Head of the Department of Cardiac and Thoracic Aortic Surgery, emphasises the significance: "The introduction of this new implant represents an important advance in cardiac surgery. It will enable us to take the care of patients with complex aortic diseases to a new level. It is further proof of the high innovation potential of our clinic and our close cooperation with international partners."
The successful application of the new system on a 58-year-old Viennese man marks a significant step forward in the treatment of complex aortic procedures at University Hospital Vienna.